Prostate cancer academic gets university research impact award

01 November 2019
A Cambridge University Hospital’s NHS Foundation Trust specialist has won a prestigious award.

University lecturer and honorary consultant urologist, Vincent Gnanapragasam, has been awarded a Established Researcher and Academic Champion prize in this year's University of Cambridge Vice-Chancellor’s Research Impact and Engagement Awards.Vincent Gnanapragasam with vice-chancellor Stephen Toope

The awards recognise outstanding achievement, innovation and creativity with a clear impact and benefit for patients and the public.  Mr Gnanapragasam and his colleagues were selected for developing a new decision-making web application, called Predict Prostate, to help doctors and patients make informed choices about prostate cancer treatment.

Predict Prostate takes patient information such as blood test results, the cancer grade and stage, and details about the patient’s age and overall health to calculate 10 and 15-year survival estimates and whether treatment would make a difference. The data was obtained from over 10,000 men from the UK

Mr Gnanapragasam, who has previously developed a safer prostate biopsy device called CamProbe, said: “I am very humbled to receive this award on behalf of my colleagues and co-investigators which specifically recognises the research benefit of our work to the public. This was only possible with the joint working between the Academic Urology Group, Public Health England, the Department of Cancer Epidemiology and the Winton Centre for Risk Communication.”

Predict Prostate is free to use anywhere in the world and has already been used more than 23,000 times worldwide since its launch in March 2019. It is the first such resource to be endorsed by the National Institute for Health and Care Excellence (NICE) in support of its guidelines. It can be accessed via the link below.